Needle Free Drug Delivery Devices Market : Opportunities and Forecasts by 2023

Needle Free Drug Delivery Devices Market : Opportunities and
Forecasts by 2023
Drug delivery plays a vital role in human health care. Needle free drug
delivery devices are novel drug delivery devices to inject drugs into a
patients’ body without invading the skin tissue with a conventional
needle. The first needle free injection systems were developed in the
1940s and 1950s for the U.S. soldiers. These are now poised to
become mainstream. Lesser pain and stress; elimination of the need
for needle disposal, consistency in drug delivery, and zero risk of
broken needles are the major advantages of needle free drug delivery

devices over conventional drug delivery devices. Hence, the global
needle free drug delivery devices market is likely to witness strong
growth during the forecast period from 2015–2023. However, high
start-up cost and requirement for training and maintenance are some
of restraints of the market.
Read Complete Report @ http://www.mrrse.com/needle-freedelivery-devices-market
The global needle free drug delivery devices market has been
segmented based on technology and application of devices. Based on
technology, the market has been segmented into jet injectors and
competing needle-free technologies. The competing needle-free
technologies segment accounted for the highest share of the market in
2014. However, the jet injectors segment is expected to grow at a
higher rate during the forecast period due to rising incidence of
needlestick injuries. Additionally, continuous evolution in jet injector
technology is anticipated to drive the market during the forecast
period. Novel needle technology, inhaler technology, and transdermal

patch technology are included in the competing needle-free
technologies segment. The novel needle technology sub-segment
accounted for the highest share of the competing needle-free
technologies segment in 2014. However, the transdermal patch
technology segment is likely to witness highest growth rate during the
forecast period. Controlled drug delivery and elimination of presystemic
metabolism are the major factors driving the transdermal
patch technology segment. Based on application, the market has been
segmented into vaccine delivery, pain management, insulin delivery,
pediatric injections, and others. The insulin delivery segment
accounted for the largest share of the market in 2014. The segment is
expected to maintain its leadership position during the forecast period.
However, the pediatric injections segment is likely to grow at the
highest rate during the forecast period due to public awareness and
government initiatives for pediatric vaccination.
Enquiry For This Report @ http://www.mrrse.com/enquiry/1185

Geographically, the needle free drug delivery devices market has been
classified into five major regions: North America, Europe, Asia Pacific,
Latin America, and Middle East & Africa. North America accounted for
the largest share of the global needle free drug delivery devices
market in 2014. The region is expected to maintain its market position
during the forecast period from 2015 to 2023. This is due to high
awareness about novel drug delivery systems, presence of major key
players, and high investment in research and development activities.
However, Asia Pacific is likely to witness the highest CAGR during the
forecast period due to increase in health care infrastructure and
distribution strategies adopted by the market players. Europe
accounted for the second largest share of the market in 2014 due to
high geriatric population that would increase demand for convenient
drug delivery options. Latin America is likely to record the second
highest growth during the forecast period due to rising prevalence of
chronic diseases, improving health care scenario, and growing
investment by leading players.

Request a Sample Copy of the Report @
http://www.mrrse.com/sample/1185
The needle free drug delivery devices market is consolidated.
However, Zogenix, Inc., 3M, and Antares Pharma, Inc. dominated the
global market in 2014. Other players operating in the market are Glide
Pharmaceutical Technologies Ltd., Injex Pharma AG, and Pharmajet,
Inc. Partnerships and novel distribution strategies of the leading
companies would help boost market growth during the forecast period.
In March 2013, Zogenix, Inc. and Battelle extended their co-marketing
partnership for the DosePro needle-free drug delivery system through
March 29, 2014.
Table of Content
1. Preface
2. Executive Summary
3. Needle Free Drug Delivery Devices Market - Industry Analysis
4. Market Segmentation - By Technology

5. Market Segmentation - By Application
6. Market Segmentation - By Geography
About MRRSE
MRRSE stands for Market Research Reports Search Engine, the
largest online catalog of latest market research reports based on
industries, companies, and countries. MRRSE sources thousands of
industry reports, market statistics, and company profiles from trusted
entities and makes them available at a click. Besides well-known
private publishers, the reports featured on MRRSE typically come from
national statistics agencies, investment agencies, leading media
houses, trade unions, governments, and embassies.

Contact US:
Corporate Office
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-730-0559
http://www.mrrse.com/
Email: sales@mrrse.com